Cargando…
Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry
The differentiation between a pulmonary metastasis and a newly developed squamous cell carcinoma of the lung in patients with prior head and neck squamous cell carcinoma (HNSCC) is difficult due to a lack of biomarkers but is crucially important for the prognosis and therapy of the affected patient....
Autores principales: | Richter, Annika, Fichtner, Alexander, Joost, Jasmin, Brockmeyer, Philipp, Kauffmann, Philipp, Schliephake, Henning, Hammerstein‐Equord, Alexander, Kueffer, Stefan, Urlaub, Henning, Oellerich, Thomas, Ströbel, Philipp, Bohnenberger, Hanibal, Bremmer, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682946/ https://www.ncbi.nlm.nih.gov/pubmed/34647699 http://dx.doi.org/10.1002/cjp2.244 |
Ejemplares similares
-
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer
por: Elakad, Omar, et al.
Publicado: (2022) -
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
por: Bohnenberger, Hanibal, et al.
Publicado: (2015) -
One carbon metabolism in human lung cancer
por: Yao, Sha, et al.
Publicado: (2021) -
Expression and prognostic impact of CD49b in human lung cancer
por: Tirilomi, Anna, et al.
Publicado: (2022) -
Role of Annexin A1 in Squamous Cell Lung Cancer Progression
por: Elakad, Omar, et al.
Publicado: (2021)